Literature DB >> 23585946

Thymic neoplasm: a rare disease with a complex clinical presentation.

Omar M Rashid1, Anthony D Cassano, Kazuaki Takabe.   

Abstract

Thymic neoplasms constitute a broad category of rare lesions with a wide spectrum of pathologic characteristics and clinical presentations which therefore require a high index of suspicion to diagnose. The natural history of the disease is seldom predictable, anywhere from an indolent to an aggressively malignant course. Although the classification and staging of these lesions are complex and controversial, complete radical surgical resection remains the gold standard of therapy. Radiation and chemotherapy are important elements of the multimodality approach to treating these patients and it is important for thoracic surgeons to work closely with their colleagues in other disciplines in the management of and future research endeavors in thymic neoplasm. In this review, we discuss the evaluation of the patient with an anterior mediastinal mass, the classification and staging of thymic neoplasms, the role of surgery, radiation and chemotherapy in treating this disease, as well as future directions in research for novel targeted therapies.

Entities:  

Keywords:  Thymic neoplasm; thymic carcinoma; thymoma

Year:  2013        PMID: 23585946      PMCID: PMC3621939          DOI: 10.3978/j.issn.2072-1439.2013.01.12

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  142 in total

1.  Thymoma: a clinicopathologic study.

Authors:  P E BERNATZ; E G HARRISON; O T CLAGETT
Journal:  J Thorac Cardiovasc Surg       Date:  1961-10       Impact factor: 5.209

2.  Extended transcervical video-assisted thymectomy.

Authors:  Christopher B Komanapalli; James I Cohen; Mithran S Sukumar
Journal:  Thorac Surg Clin       Date:  2010-05       Impact factor: 1.750

3.  The value of transcapsular invasion in patients with thymoma.

Authors:  Federico Venuta; Marco Anile; Erino A Rendina; Domenico Vitolo; Tiziano De Giacomo; Giorgio F Coloni
Journal:  Arch Pathol Lab Med       Date:  2009-09       Impact factor: 5.534

4.  Adjuvant radiotherapy after complete resection of thymoma.

Authors:  M Haniuda; M Morimoto; H Nishimura; O Kobayashi; T Yamanda; F Iida
Journal:  Ann Thorac Surg       Date:  1992-08       Impact factor: 4.330

5.  Prognostic factors and long-term results after thymoma resection: a series of 307 patients.

Authors:  J F Regnard; P Magdeleinat; C Dromer; E Dulmet; V de Montpreville; J F Levi; P Levasseur
Journal:  J Thorac Cardiovasc Surg       Date:  1996-08       Impact factor: 5.209

6.  Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas.

Authors:  Giuseppe Giaccone; Arun Rajan; Rita Ruijter; Egbert Smit; Cees van Groeningen; Pancras C W Hogendoorn
Journal:  J Thorac Oncol       Date:  2009-10       Impact factor: 15.609

7.  Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma.

Authors:  Girum L Lemma; Ju-Whei Lee; Seena C Aisner; Corey J Langer; William J Tester; David H Johnson; Patrick J Loehrer
Journal:  J Clin Oncol       Date:  2011-04-18       Impact factor: 44.544

8.  Long-term outcome after multimodality treatment for stage III thymic tumors.

Authors:  Federico Venuta; Erino A Rendina; Flavia Longo; Tiziano De Giacomo; Marco Anile; Edoardo Mercadante; Luigi Ventura; Mattia F Osti; Federico Francioni; Giorgio F Coloni
Journal:  Ann Thorac Surg       Date:  2003-12       Impact factor: 4.330

9.  Thymoma: a clinicopathologic study based on the new World Health Organization classification.

Authors:  Kazuo Nakagawa; Hisao Asamura; Yoshihiro Matsuno; Kenji Suzuki; Haruhiko Kondo; Arafumi Maeshima; Etsuo Miyaoka; Ryosuke Tsuchiya
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

10.  Motesanib diphosphate (AMG 706), an oral angiogenesis inhibitor, demonstrates clinical efficacy in advanced thymoma.

Authors:  Arun Azad; Rebecca A Herbertson; David Pook; Shane White; Paul L R Mitchell; Niall C Tebbutt
Journal:  Acta Oncol       Date:  2009       Impact factor: 4.089

View more
  9 in total

1.  Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma.

Authors:  Nicola Tamburini; Luca Morandi; Rosa Rinaldi; Pio Maniscalco; Francesco Quarantotto; Elena Montinari; Alberto Papi; Gabriele Anania; Giorgio Cavallesco
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Response to nab-paclitaxel and nedaplatin in a heavily-metastatic thymic carcinoma: A case report.

Authors:  Ping Zhan; Haiyan Xie; Li-Ke Yu
Journal:  Oncol Lett       Date:  2015-02-10       Impact factor: 2.967

3.  Management of metastatic malignant thymoma with advanced radiation and chemotherapy techniques: report of a rare case.

Authors:  Mark A D'Andrea; G Kesava Reddy
Journal:  World J Surg Oncol       Date:  2015-02-25       Impact factor: 2.754

4.  Thymic epithelial tumors: Do we know all the prognostic factors?

Authors:  Magdalena Knetki-Wróblewska; Dariusz M Kowalski; Marta Olszyna-Serementa; Maciej Krzakowski; Małgorzata Szołkowska
Journal:  Thorac Cancer       Date:  2021-01-02       Impact factor: 3.500

Review 5.  Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors.

Authors:  Valentina Tateo; Lisa Manuzzi; Andrea De Giglio; Claudia Parisi; Giuseppe Lamberti; Davide Campana; Maria Abbondanza Pantaleo
Journal:  Int J Mol Sci       Date:  2020-11-28       Impact factor: 5.923

6.  Oncological resection, myasthenia gravis and staging as prognostic factors in thymic tumours: a Chilean case series.

Authors:  Patricio Salas; Maria Eliana Solovera; Felipe Bannura; Matias Muñoz-Medel; Miguel Cordova-Delgado; Cesar Sanchez; Carolina Ibañez; Marcelo Garrido; Erica Koch; Francisco Acevedo; Sebastian Mondaca; Bruno Nervi; Jorge Madrid; Jose Peña; Mauricio P Pinto; José Valbuena; Hector Galindo
Journal:  Ecancermedicalscience       Date:  2021-03-09

7.  Unraveling the Role of Histone Variant CENP-A and Chaperone HJURP Expression in Thymic Epithelial Neoplasms.

Authors:  Georgia Levidou; Konstantinos Palamaris; Alexandros G Sykaras; Georgios Andreadakis; Christos Masaoutis; Irene Theochari; Penelope Korkolopoulou; Dimitra Rontogianni; Stamatios Theocharis
Journal:  Int J Mol Sci       Date:  2022-07-28       Impact factor: 6.208

8.  A case of co-existing paraganglioma and thymoma.

Authors:  G Bano; D Sennik; M Kenchaiah; Ye Kyaw; Katie Snape; V Tripathi; P Wilson; I Vlahos; I Hunt; S Hodgson
Journal:  Springerplus       Date:  2015-10-21

9.  Ephrin Receptors (Ephs) Expression in Thymic Epithelial Tumors: Prognostic Implications and Future Therapeutic Approaches.

Authors:  Christos Masaoutis; Natalia Georgantzoglou; Panagiotis Sarantis; Irene Theochari; Nikolaos Tsoukalas; Mattheos Bobos; Paraskevi Alexandrou; Alexandros Pergaris; Dimitra Rontogianni; Stamatios Theocharis
Journal:  Diagnostics (Basel)       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.